LOGIN  |  REGISTER
Astria Therapeutics
Chimerix

CareCloud's medSR Division to Exhibit in Booth 404 at Becker’s 11th Annual CEO + CFO Roundtable

October 24, 2023 | Last Trade: US$1.12 0.07 6.67

SOMERSET, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology services for medical practices and health systems nationwide, today announced it’s medSR division’s participation at Becker’s highly-anticipated 11th Annual CEO + CFO Roundtable event. Taking place November 13-16, 2023, at the Hyatt Place Regency in Chicago, this event will bring together an elite group of chief executive officers, chief financial officers, and healthcare executives from top hospitals and health systems. CareCloud's medSR division will be exhibiting in booth 404, where they will highlight their healthcare IT consulting and implementation services.

The Becker’s CEO + CFO Roundtable is renowned for convening thought leaders, influencers, and decision-makers in the healthcare sector. Attendees can expect an agenda brimming with captivating conversations and discussions on the most critical issues currently facing the industry. Key topics on the agenda include rural healthcare, digital transformation, health equity, C-suite diversity, and more. CareCloud's medSR Division is dedicated to playing a vital role in addressing these challenges and is eager to engage in these pivotal conversations at the event.

medSR, a leading provider of healthcare IT consulting and implementation services, boasts over three decades of invaluable experience, helping healthcare organizations of all sizes successfully implement and optimize their electronic health record (EHR) systems. Their knowledgeable team possesses a deep understanding of the unique challenges and opportunities facing healthcare organizations in today's complex environment. Offering comprehensive services, including project management, subject matter experts (SMEs), information technology (IT) staffing, interim leadership, training, and activation, medSR's seasoned professionals leverage their extensive MEDITECH and operational experience to ensure client objectives are not only met but exceeded cost-effectively.

"The CEO + CFO Roundtable provides an exceptional opportunity for medSR to strengthen our position within the health system sector," stated Dwight Garvin, executive vice president and chief operating officer at medSR. "medSR has recently sealed a series of highly successful deals, fortifying a solid foundation for our future initiatives. Our commitment to seizing these opportunities is unwavering, and we are poised for a promising year ahead."

To learn more about medSR and their innovative healthcare services, visit booth 404 at Becker’s 11th Annual CEO + CFO Roundtable event or visit their website at medSR.com.

About CareCloud

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.

Follow CareCloud on LinkedInTwitter and Facebook.

Company Contact:
Larry Steenvoorden
Chief Financial Officer
This email address is being protected from spambots. You need JavaScript enabled to view it.

Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Chimerix

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Surmodics

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB